REG - UBS Asset Management Takeda Pharma.Co.Ltd Shire plc - Form 8.3 - Shire plc replacement (2)

Takeda Pharmaceutical CoAnnouncement

28/12/2018 11:30

For best results when printing this announcement, please click on link below:
http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20181224:nRSX7265La

RNS Number : 7265L
UBS Asset Management
28 December 2018
 
This form replaces the previous RNS announcement  6053L released at 15:15 on
27 December 2018. Amendments made to sections 2. (a) and 3 (a)&(d). All
other information remains unchanged.
FORM 8.3
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
 
1.         KEY INFORMATION
 
 (a) Full name of discloser:                                                      UBS Asset Management *
 (b) Owner or controller of interests and short positions disclosed, if
 different from 1(a):
      The naming of nominee or vehicle companies is insufficient.  For a
 trust, the trustee(s), settlor and beneficiaries must be named.
 (c) Name of offeror/offeree in relation to whose relevant securities this form   Shire PLC
 relates:
      Use a separate form for each offeror/offeree
 (d) If an exempt fund manager connected with an offeror/offeree, state this
 and specify identity of offeror/offeree:
                                                                                  n/a
 (e) Date position held/dealing undertaken:                                       21 Dec 2018
      For an opening position disclosure, state the latest practicable date
 prior to the disclosure
 (f)  In addition to the company in 1(c) above, is the discloser making           Yes
 disclosures in respect of any other party to the offer?
                                                                                Takeda Pharmaceutical
      If it is a cash offer or possible cash offer, state "N/A"
 
2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE
 
If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
 
(a)        Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates following the dealing
(if any)
 
 
 Class of relevant security:                                          SHIRE ORD GBP0.05
                                                                      Interests                              Short positions
                                                                      Number                      %          Number                      %
 (1) Relevant securities owned and/or controlled:                     1,539,600                      0.17                 0                 0.00
 (2) Cash-settled derivatives:                                                     0                 0.00                 0                 0.00
 (3) Stock-settled derivatives (including options) and agreements to               0                 0.00                 0                 0.00
 purchase/sell:
                                                                      1,539,600                      0.17                 0                 0.00
      TOTAL:
 
 
All interests and all short positions should be disclosed.
 
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
 
(b)        Rights to subscribe for new securities (including directors'
and other employee options)
 
 Class of relevant security in relation to which subscription right exists:
 Details, including nature of the rights concerned and relevant percentages:
 
3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
 
Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
(a)        Purchases and sales
 
 Class of relevant security  Purchase/sale  Number of securities    Price per unit
 Ordinary Shares             SALE                   27,879              44.895000 GBP
 Ordinary Shares             SALE                    1,433              44.895000 GBP
 Ordinary Shares             SALE                4,626,117              44.918126 GBP
                             TOTAL SALE     4,655,429
 
(b)        Cash-settled derivative transactions
 
 Class of relevant security  Product description  Nature of dealing                                                              Number of reference securities  Price per unit
                             e.g. CFD             e.g. opening/closing a long/short position, increasing/reducing a long/short
                                                  position
 
(c)        Stock-settled derivative transactions (including options)
 
(i)         Writing, selling, purchasing or varying
 
 Class of relevant security  Product description e.g. call option  Writing, purchasing, selling, varying etc.  Number of securities to which option relates  Exercise price per unit  Type                           Expiry date  Option money paid/ received per unit
                                                                                                                                                                                      e.g. American, European etc.
 
(ii)        Exercise
 
 Class of relevant security  Product description  Exercising/ exercised against  Number of securities  Exercise price per unit
                             e.g. call option
 
(d)        Other dealings (including subscribing for new securities)
 
 Class of relevant security  Nature of dealing               Details                   Price per unit (if applicable)
                             e.g. subscription, conversion
 SHIRE ORD GBP0.05           TRANSFER IN                                662                44.918126 GBP
 SHIRE ORD GBP0.05           TRANSFER OUT                               662                44.918126 GBP
 
4.         OTHER INFORMATION
 
(a)        Indemnity and other dealing arrangements
 
 Details of any indemnity or option arrangement, or any agreement or
 understanding, formal or informal, relating to relevant securities which may
 be an inducement to deal or refrain from dealing entered into by the person
 making the disclosure and any party to the offer or any person acting in
 concert with a party to the offer:
 Irrevocable commitments and letters of intent should not be included.  If
 there are no such agreements, arrangements or understandings, state "none"
 
(b)        Agreements, arrangements or understandings relating to
options or derivatives
 
 Details of any agreement, arrangement or understanding, formal or informal,
 between the person making the disclosure and any other person relating to:
 (i)  the voting rights of any relevant securities under any option; or
 (ii) the voting rights or future acquisition or disposal of any relevant
 securities to which any derivative is referenced:
 If there are no such agreements, arrangements or understandings, state "none"
 
(c)        Attachments
 
 Is a Supplemental Form 8 (Open Positions) attached?  NO
 
 
 Date of disclosure:  28/12/2018
 Contact name:        Mr James Mortimer
 Telephone number:    +44 20 7901 5828
 
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service and must also be emailed to the Takeover Panel at
monitoring@disclosure.org.uk (mailto:monitoring@disclosure.org.uk) .  The
Panel's Market Surveillance Unit is available for consultation in relation to
the Code's dealing disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
(http://www.thetakeoverpanel.org.uk) .
 
 
* this report is on behalf of:
 
UBS AG (UBS Asset Management operating in Switzerland)
 
UBS Asset Management (Americas) Inc.
 
UBS Asset Management (Australia) Ltd
 
UBS Asset Management (Hong Kong) Limited
 
UBS Asset Management (Singapore) Ltd
 
UBS Asset Management (Taiwan) Ltd
 
UBS Asset Management (UK) Ltd
 
UBS La Maison de Gestion
 
 
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.